ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

Siemens To Provide Technology To DxTx For Lung Cancer Detection.

December 14, 2001

In Brief: Construction Grant Applications Due Oct. 1 For Funding In FY 1982; Backlog Cleared Out

June 19, 1981

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

Coalition Members Urged To Demand Intent Of Congress In Cancer Act Be Recognized

March 13, 1981

“We’d Ban Cigarettes’ If Nicotine Were a Drug, FDA Commissioners Says

February 14, 1992